Robert J. Linhardt

Professor
Department of Biological Sciences
Biology Rensselaer Polytechnic Institute
United States of America

Biography

After 21 years on the faculty of the University of Iowa, Linhardt joined Rensselaer in 2003 as a senior constellation professor. During his career in Iowa, he spent eight years as the universityís F. Wendell Miller Distinguished Professor of Chemistry and ten years as a member of the Executive Committee of the Center for Biocatalysis and Bioprocessing. Linhardt began his professional career with a three-year postdoctorate in chemical engineering at Massachusetts Institute of Technology and received his Ph.D. in Organic Chemistry from The Johns Hopkins University, 1979 and M.A. in 1977 .Among the many honors Linhardt has received include the Scientific American 10 (2009), Claude S. Hudson Award from the American Chemical Society (2003), the Volweiler Research Achievement Award in Pharmaceutical Sciences (1999), the Horace S. Isbell Award from The Carbohydrate Division of the American Chemical Society (1994), the Iowa Regents Award for Faculty Excellence (1992), and the University of Iowa Excellence in Teaching Award (1989). Linhardt is a member of many professional societies including American Chemical Society, American Society of Biochemistry and Molecular Biology, American Association for the Advancement of Science (AAAS), Society for Glycobiology, American Association of Colleges of Pharmacy, and American Association of Pharmaceutical Scientists. Linhardt has been a consultant to industry and government for nearly 30 years

Research Intrest

Glycoscience, Biocatalysis, Metabolic Engineering

List of Publications
Bioengineered heparins and heparan sulfates, L. Fu, M. Suflita, R. J. Linhardt, Advanced Drug Delivery Reviews, 97, 237–249, 2016.
Urinary glycosaminoglycans predict outcomes in septic shock and ARDS, E. P. Schmidt, K. H. Overdier, X. Sun, L. Lin, X. Liu, Y. Yang, L. A. Ammons, T. D. Hiller, M. A. Suflita, Y. Yu, Y. Chen, F. Zhang, C. Cothren Burlew, C. L. Edelstein, I. S. Douglas, R. J. Linhardt, American Journal of Respiratory and Critical Care Medicine, in press, 2016.
[1].Rapid generation of CRISPR/dCas9-regulated, orthogonally repressible hybrid T7-lac promoters for modular, tuneable control of metabolic pathway fluxes in E. coli, B. Cress, J. Jones, K. Daniel, Q. Leitz, J. Englaender, S. Collins, R. J. Linhardt, M. Koffas, Nucleic Acids Research, in press, 2016.